↓ Skip to main content
What is this page? Embed badge

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis

Overview of attention for book
Cover of 'Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Evidence for an Early Treatment of Multiple Sclerosis
  3. Altmetric Badge
    Chapter 2 Inflammation, Demyelination, and Axonal Degeneration: Three Aspects of the Pathogenesis of Multiple Sclerosis Revealed by Campath-1H Treatment
  4. Altmetric Badge
    Chapter 3 Genetic Regulation of Nerve Cell Death/Glial Activation and Protective Effects of Myelin Basic Protein Autoimmune Neurotrophin Production in Mechanically Induced Neurodegeneration
  5. Altmetric Badge
    Chapter 4 Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: a Phase I/II Study with Riluzole
  6. Altmetric Badge
    Chapter 5 Neuropathology and Disease Progression in Multiple Sclerosis
  7. Altmetric Badge
    Chapter 6 Autoimmune Inflammation and Multiple Sclerosis
  8. Altmetric Badge
    Chapter 7 Early Treatment of Progression in Multiple Sclerosis
  9. Altmetric Badge
    Chapter 8 Imaging for Tissue Characterization in Multiple Sclerosis and Other White Matter Diseases
  10. Altmetric Badge
    Chapter 9 Monounsaturated Fatty Acids and Neuroprotection. The Results of a Study of Cognitive Decline in Old Age. Is There a Case for this Treatment in Multiple Sclerosis?
  11. Altmetric Badge
    Chapter 10 Neuroprotection in Acute Ischemic Stroke: Lessons for Early Treatment in Multiple Sclerosis
  12. Altmetric Badge
    Chapter 11 Soluble VCAM-1 Release Indicates Inflammatory Blood-Brain Barrier Pathology and Further Modulates Adhesion
  13. Altmetric Badge
    Chapter 12 Early Treatment in Multiple Sclerosis with Intravenous Immunoglobulin: Rationale and Study Design
  14. Altmetric Badge
    Chapter 13 Serial Magnetic Resonance Imaging in Patients with a First Clinical Episode Suggestive of Multiple Sclerosis: Outline of a Research Protocol
  15. Altmetric Badge
    Chapter 14 T1-Hypointense Lesions (T1 Black Holes) in Mild-to-Moderate Disability Relapsing Multiple Sclerosis
  16. Altmetric Badge
    Chapter 15 Acute Monosymptomatic Optic Neuritis: Potential Clues to Early Therapy in Multiple Sclerosis
  17. Altmetric Badge
    Chapter 16 Antibody Mediated Demyelination
  18. Altmetric Badge
    Chapter 17 Anti-MOG Antibodies as Early Predictors for Conversion to Relapsing-Remitting Disease Course in Patients Suggestive of Multiple Sclerosis
  19. Altmetric Badge
    Chapter 18 Sunlight, Vitamin D, and Multiple Sclerosis
  20. Altmetric Badge
    Chapter 19 The Yin and Yang of Inflammation in Multiple Sclerosis
  21. Altmetric Badge
    Chapter 20 Management of Interferon-β1b (Betaseron) Failures in Multiple Sclerosis with Interferon-αn3 (Alferon N)
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

blogs
1 blog

Readers on

mendeley
1 Mendeley
Summary Blogs
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Published by
Springer Milan, December 2012
DOI 10.1007/978-88-470-2117-4
ISBNs
978-8-84-702171-6, 978-8-84-702117-4
Editors

Hommes, Otto R., Comi, Giancarlo

View on publisher site
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 100%
Readers by discipline Count As %
Medicine and Dentistry 1 100%

This page is provided by Altmetric.